Related Experiment Video
Updated: Jun 25, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
Published on: July 17, 2020
Atonal homolog 1 is a tumor suppressor gene
Wouter Bossuyt1, Avedis Kazanjian, Natalie De Geest
1Laboratory of Neurogenetics, Department of Molecular and Developmental Genetics, VIB, Leuven, Belgium.
Abstract:
Colon cancer accounts for more than 10% of all cancer deaths annually. Our genetic evidence from Drosophila and previous in vitro studies of mammalian Atonal homolog 1 (Atoh1, also called Math1 or Hath1) suggest an anti-oncogenic function for the Atonal group of proneural basic helix-loop-helix transcription factors. We asked whether mouse Atoh1 and human ATOH1 act as tumor suppressor genes in vivo. Genetic knockouts in mouse and molecular analyses in the mouse and in human cancer cell lines support a tumor suppressor function for ATOH1. ATOH1 antagonizes tumor formation and growth by regulating proliferation and apoptosis, likely via activation of the Jun N-terminal kinase signaling pathway. Furthermore, colorectal cancer and Merkel cell carcinoma patients show genetic and epigenetic ATOH1 loss-of-function mutations. Our data indicate that ATOH1 may be an early target for oncogenic mutations in tissues where it instructs cellular differentiation.
Insights
The Atonal homolog 1 (Atoh1) gene acts as a tumor suppressor, inhibiting colon cancer growth by regulating cell proliferation and apoptosis. Loss of ATOH1 function is linked to colorectal cancer development.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Colon cancer is a leading cause of cancer mortality.
- Atonal homolog 1 (Atoh1) is a transcription factor with suggested anti-oncogenic roles.
Purpose of the Study:
- To investigate the in vivo tumor suppressor function of mouse Atoh1 and human ATOH1.
- To explore the mechanisms by which ATOH1 antagonizes tumor formation and growth.
Main Methods:
- Genetic knockout models in mice.
- Molecular analyses of mouse and human cancer cell lines.
- Investigation of the Jun N-terminal kinase signaling pathway.
Main Results:
- Mouse Atoh1 and human ATOH1 exhibit tumor suppressor activity in vivo.
- ATOH1 regulates cell proliferation and apoptosis, likely through the Jun N-terminal kinase pathway.
- Loss-of-function mutations in ATOH1 are observed in colorectal cancer and Merkel cell carcinoma patients.
Conclusions:
- ATOH1 functions as a tumor suppressor gene in vivo.
- ATOH1 plays a critical role in preventing tumor formation and growth.
- ATOH1 may be an early target for oncogenic mutations in differentiating tissues.
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Negative Regulator Molecules